Skip to main content

STIFEL FINANCIAL CORP

Position in GILD — Gilead Sciences, Inc.

CIK 720672 ST. LOUIS, MO

Position in GILD

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$167,567,475
-$2,632,397 QoQ
Shares Held
1,202,321
-13.3% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 89.8341624241779.ToString("F0")% Shared 0.5016963024017712.ToString("F0")% None 9.664141273420327.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $5,042,614,731 across 16 Drug Manufacturers - General names. GILD ranks #7 (3.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 GILD
Gilead Sciences, Inc.
This page
1,202,321 $167,567,475

All Filings in GILD

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $167,567,475 1,202,321
2025-12-31 $170,199,872 1,386,670
2025-09-30 $148,237,392 1,335,472
2025-06-30 $162,401,374 1,464,791
2025-03-31 $167,115,849 1,491,440
2024-12-31 $156,488,910 1,694,153
2024-09-30 $152,761,843 1,822,064
2024-06-30 $125,189,507 1,824,654
2024-03-31 $133,376,894 1,820,845
2023-12-31 $133,493,701 1,647,867
2023-09-30 $125,064,141 1,668,857
2023-06-30 $126,285,279 1,638,579
2023-03-31 $139,372,009 1,679,788
2022-12-31 $160,844,779 1,873,556
2022-09-30 $119,292,171 1,933,736
2022-06-30 $117,148,798 1,895,305
2022-03-31 $107,964,229 1,816,051
2021-12-31 $129,538,850 1,784,036
2021-09-30 $120,634,298 1,727,048
2021-06-30 $118,690,535 1,723,650
2021-03-31 $112,610,663 1,742,390
2020-12-31 $99,401,111 1,706,164
2020-09-30 $121,550,891 1,923,578
2020-06-30 $147,174,060 1,912,842
2020-03-31 $143,188,496 1,915,309